Related Experiment Video
Updated: Jan 19, 2026

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
Published on: January 7, 2022
Myrtenol Attenuates MRSA Biofilm and Virulence by Suppressing sarA Expression Dynamism
Anthonymuthu Selvaraj1, Thangaraj Jayasree1, Alaguvel Valliammai1
1Department of Biotechnology, Alagappa University, Karaikudi, India.
Abstract:
Methicillin-resistant Staphylococcus aureus (MRSA) is a deleterious human pathogen responsible for severe morbidity and mortality worldwide. The pathogen has attained high priority in the World Health Organization (WHO) - Multidrug-resistant (MDR) pathogens list. Emerging MDR strains of S. aureus are clinically challenging due to failure in conventional antibiotic therapy. Biofilm formation is one of the underlying mechanisms behind the antibiotic resistance. Hence, attenuating biofilm formation has become an alternative strategy to control persistent infections. The current study is probably the first that focuses on the antibiofilm and antivirulence potential of myrtenol against MRSA and its clinical isolates. Myrtenol exhibited a concentration-dependent biofilm inhibition without causing any harmful effect on cell growth and viability. Further, microscopic analysis validated the biofilm inhibitory efficacy of myrtenol against MRSA. In addition, myrtenol inhibited the synthesis of major virulence factors including slime, lipase, α-hemolysin, staphyloxanthin and autolysin. Inhibition of staphyloxanthin in turn sensitized the MRSA cells to healthy human blood and hydrogen peroxide (H2O2). Notably, myrtenol treated cells were deficient in extracellular DNA (eDNA) mediated autoaggregation as eDNA releasing autolysis was impaired by myrtenol. Biofilm disruptive activity on preformed biofilms was observed at concentrations higher than minimum biofilm inhibitory concentration (MBIC) of myrtenol. Also, the non-cytotoxic effect of myrtenol on human peripheral blood mononuclear cell (PBMC) was evidenced by trypan blue and Alamar blue assays. Transcriptional analysis unveiled the down-regulation of global regulator sarA and sarA mediated virulence genes upon myrtenol treatment, which is well correlated with results of phenotypic assays. Thus, the results of the present study revealed the sarA mediated antibiofilm and antivirulence potential of myrtenol against MRSA.
Insights
Myrtenol effectively inhibits biofilm formation and virulence in Methicillin-resistant Staphylococcus aureus (MRSA) without harming cells. This natural compound offers a promising strategy against antibiotic-resistant infections.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) is a major global health threat due to multidrug resistance (MDR).
- Biofilm formation is a key mechanism conferring antibiotic resistance in MRSA, necessitating alternative therapeutic strategies.
- Targeting biofilm and virulence factors presents a promising approach to combat persistent MRSA infections.
Purpose of the Study:
- To investigate the antibiofilm and antivirulence potential of myrtenol against MRSA.
- To evaluate the effect of myrtenol on MRSA cell viability and key virulence factors.
- To explore the underlying molecular mechanisms of myrtenol's action, including gene regulation.
Main Methods:
- MRSA isolates were treated with varying concentrations of myrtenol.
- Biofilm inhibition, cell viability (trypan blue, Alamar blue assays), virulence factor synthesis, and biofilm disruption were assessed.
- Transcriptional analysis of the global regulator `sarA` and its mediated genes was performed.
Main Results:
- Myrtenol demonstrated concentration-dependent inhibition of MRSA biofilm formation without affecting cell viability.
- Myrtenol suppressed key virulence factors (slime, lipase, α-hemolysin, staphyloxanthin, autolysin) and disrupted pre-formed biofilms.
- Myrtenol treatment led to down-regulation of `sarA` and its associated virulence genes, correlating with phenotypic observations.
Conclusions:
- Myrtenol exhibits significant antibiofilm and antivirulence properties against MRSA.
- The compound's efficacy is linked to the down-regulation of the `sarA` regulatory pathway.
- Myrtenol represents a potential non-cytotoxic therapeutic agent for combating MRSA infections.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Biofilms
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Antimicrobial Effectiveness
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

